Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > New job posting
View:
Post by scarlet1967 on Jan 27, 2023 2:47pm

New job posting

"review protocol/protocol amendment"
 





Check out this job at Theratechnologies Inc.: 
https://www.linkedin.com/jobs/view/3453350454

Comment by scarlet1967 on Jan 27, 2023 2:54pm
"Audit activities to ensure that Theratechnologies pre-clinical and clinical studies are conducted according to protocols and that any deviation is documented and assessed" THTX isn't involved with any preclinical studies but Sort1!!
Comment by SPCEO1 on Jan 27, 2023 3:37pm
That reads to me like an indictment of Christian. Perhaps on further review, the great preclinical work may have had some flaws? Or, it could be they found protocols were not being followed in the phase 1a and 1b leading to the pause due to weird results. There clearly is a big gap between the preclinical results and the still unknown phase 1a and 1b results, so I am sure they are trying to figure ...more  
Comment by SABBOBCAT on Jan 27, 2023 3:48pm
Again, if preclinical wasn't sound, you would scrap the program and go back to the drawing board. To me, this reads as if there was lack of governance relating to the trial. Whether that be lack of proper protocols or poor communication or both, who knows. But this does indicate they want to move something forward.
Comment by palinc2000 on Jan 27, 2023 4:01pm
If they have indeed idenfied less than strict adherence to stringent clinial and pre clinical methods and procedires and reporting etc   that could be good news in the sense that they might be able to pivot and come up with corrective measures / As I said before going from a strictky  HIV focused company and overnight improvising to become a company involved in research in ...more  
Comment by stockman75 on Jan 28, 2023 4:20am
Isn't that why we have an overpaid CEO from Pfizer?? I see where Goldman Sachs CEO is receiving a 29 percent pay cut for crappy results. As poorly as THTX has performed I think similar is in order for Thera.  
Comment by qwerty22 on Jan 28, 2023 10:29pm
So every cancer drug that makes it to clinic by definition passes preclinical and only 6% make it to approval so THTX are in the majority. Even passing Ph1 is only 60:40 odds I think. I'm pretty sure many of those fails thought they had som3thing special. Unfortunately I don't think this is completely unsurprising.  
Comment by palinc2000 on Jan 28, 2023 8:40am
Did they identify a flaw in the pre clinical studies which might have led them to erroneous conclusions? Qwerty do you think this is a possibility?  
Comment by ANALIAS00 on Jan 27, 2023 2:54pm
Surprised and Weird that they dont have those skills already... :o(
Comment by realitycheck4u on Jan 27, 2023 2:55pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities